DiaMedica Therapeutics Provides DM199 Preeclampsia Program Update Following Pre-IND Meeting with FDA
DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company developing novel treatments for preeclampsia (PE), fetal growth restriction (FGR) and acute ischemic stroke (AIS) ...
La Trobe researchers have made a discovery about the way dying cells are cleared from our bodies, which could have important impacts on recovery from diseases including cancer infection and ...
What you eat before, during, and after IVF has a direct impact on reproductive health, hormone balance, embryo quality, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results